Skip to main content
. 2021 Aug 2;11(8):e045225. doi: 10.1136/bmjopen-2020-045225

Table 2.

Regression analysis on symptoms reported by patients diagnosed with COVID-19

Clinical symptom People with confirmed infection (seropositive, any RT-qPCR result) (N=22) People with acute disease (RT-qPCR reactive and seropositive) (N=15)
OR 95% CI P value OR 95% CI P value
Change in taste 6.02 (1.02 to 35.51) 0.047 571.72 (1.92 to 170 629.2) 0.029
Nausea/vomiting 4.42 (0.748 to 26.09) 0.101 370.11 (2.71 to 50 429.42) 0.018
Sore throat 0.36 (0.067 to 1.93) 0.233 0.002 (0.000006 to 0.74) 0.039
Myalgia 1.15 (0.24 to 5.51) 0.865 121.82 (1.52 to 9749.08) 0.032
Breathlessness 6.90 (0.96 to 49.40) 0.054 134.46 (1.02 to 17 796.87) 0.049
Change in smell 0.77 (0.098 to 6.15) 0.811 0.37 (0.008 to 15.87) 0.607
Fever 2.97 (0.44 to 20.35) 0.266 1.44 (0.057 to 36.66) 0.825
Cough 0.12 (0.014 to 1.03) 0.053 0.011 (0.00008 to 1.42) 0.069

Symptoms associated with confirmed SARS-CoV-2 infection (antibody confirmed positive, irrespective of RT-qPCR result) among 22 patients and with acute infection (RT-qPCR reactive, antibody confirmed positive) among 15 patients, respectively.

RT-qPCR, real-time reverse transcriptase-quantitative PCR.